This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Gene Remove Gene Editing Remove Genotype Remove In-Vitro
article thumbnail

Discover how iPSC derived cells can support drug and gene therapy development

Drug Discovery World

FEBRUARY 9, 2024

DDW recently hosted a webinar ‘Discover how iPSC derived cells can be used to support the development of drug and gene therapies’, supported by DefiniGEN. In addition, stable cell lines derived from cancers represent a single and karyotypically abnormal genotype.

Gene Therapy 52
Gene Therapy Gene Development Drugs 52
article thumbnail

Nine new industry collaborations driving drug discovery forward

Drug Discovery World

MAY 29, 2024

With the integration of CRISPR/Cas9 gene editing technology we are increasing our capability to identify and validate potential drug targets, to generate more predictive pre-clinical models and to elucidate the mechanisms of action of novel therapeutics.” We see a great need for a vaccine against EBV.”

Drugs 52
Drugs Gene Editing Life Science Genome 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024